Anzeige
Mehr »
Login
Samstag, 27.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Geheimtipp: Rasanter Aufstieg, Branchenrevolution und Jahresumsatz von 50 Mio. $
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
877 Leser
Artikel bewerten:
(2)

IMCD N.V.: IMCD's growth story solidifies with the envisaged acquisition of Siyeza in South Africa

ROTTERDAM, The Netherlands (1 September 2020) - IMCD N.V. ("IMCD" or "Company"), a leading distributor of speciality chemicals and ingredients, today announces that it has successfully signed an agreement to acquire 100% of the shares in the South African distributor Siyeza Fine Chem Propriety Limited ("Siyeza").

Siyeza, based in Johannesburg, was founded in 2007 and is a leading distributor of pharmaceutical, veterinary, food, and personal care speciality chemical ingredients in South Africa. The company has 27 employees and generated a revenue of €11.7 million in 2019 through its representation of world-leading producers from Europe and Asia.

Ryan Harrison, Managing Director IMCD South Africa, comments: "For almost 15 years, IMCD South Africa has shown steady growth. As a leading speciality chemical company for the Sub-Saharan Africa market, we are focused on bringing added value to our customers and principals. I'm delighted with the acquisition of Siyeza as it solidifies IMCD's pharmaceutical business. It also places us in an ideal position to keep supporting our suppliers' growth and continue offering solutions to our customers."

Sungie Moodley, Managing Director Siyeza says: "We are very pleased to become part of the IMCD family and excited about the potential of combining our knowledge of the South African market with IMCD's global reach and strong formulation and technical know-how."

The company will continue with its present management and staff.

The closing of the transaction is subject to customary regulatory review and is expected in December 2020.

- xxx -

About IMCD N.V.
IMCD is a market leader in the sales, marketing, and distribution of speciality chemicals and food ingredients. Its result-driven professionals provide market-focused solutions to suppliers and customers across EMEA, Asia-Pacific, and Americas, offering a range of comprehensive product portfolios, including innovative formulations that embrace industry trends.

Listed at Euronext, Amsterdam (IMCD), IMCD realised revenues of EUR 2,690 million in 2019 with nearly 3,000 employees in over 50 countries on 6 continents. IMCD's dedicated team of technical and commercial experts work in close partnership to tailor best in class solutions and provide value through expertise for around 49,000 customers and a diverse range of world-class suppliers.

To find out more about IMCD, please visit www.imcdgroup.com.

Attached, please find the press release.

Media contact
IMCD Group
Maribel Rodriguez
Senior Group Communications Manager
+31 6 1479 6610
mediarelations@imcdgroup.com

Attachment

  • IMCD acquires Siyeza in South Africa (https://ml-eu.globenewswire.com/Resource/Download/a3f7fb7e-852e-4909-bcc2-8320beb80121)
Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2020 GlobeNewswire (Europe)
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.